Zobrazeno 1 - 10
of 247
pro vyhledávání: '"T. Tham"'
Autor:
A. Linderholm, C.H. Flayer, L.M. Franzi, M. Ge, M. Juarez, T. Tham, M.J. Teuber, S.-Y. Liao, M. Schivo, B.T. Kuhn, A.A. Zeki, A. Haczku
Publikováno v:
C33. ADVANCES AND UNSOLVED MYSTERIES IN COPD.
Publikováno v:
Natural Product Communications. 18:1934578X2311761
Objective Plants of Fissistigma balansae have been used for the treatment of stomachache in Vietnamese traditional medicinal remedies. This study reports 2 new sesquiterpene glycosides from the methanol extract of its branches. Methods The sample was
Autor:
M.J. Teuber, G.K. Sanghar, M. Juarez, G. Echt, K. Tuermer-Lee, T. Tham, P.A. Hernandez, A. Linderholm, T.E. Albertson, A. Haczku
Publikováno v:
D16. WILDFIRES AND WOODSMOKE.
Publikováno v:
Annals of Allergy, Asthma & Immunology. 129:S72
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Physical Review D. 104
We show that under current experimental bounds of the decays ${e}_{a}\ensuremath{\rightarrow}{e}_{b}\ensuremath{\gamma}$, the recent experimental data of the muon anomalous magnetic dipole moment $(g\ensuremath{-}2{)}_{\ensuremath{\mu}}$ can be expla
Autor:
N.J. Kenyon, M. McCartney, E. Borras, A. Linderholm, T. Tham, K. Ramirez, R.W. Harper, C. Davis
Publikováno v:
TP92. TP092 CLINICAL ADVANCES IN SARS-COV-2 AND COVID-19.
Autor:
S. Cho, Angela L. Linderholm, Angela Franciska Haczku, Maya Juarez, Satya Dandekar, N. Mohapatra, Timothy E Albertson, M.G. Weber, P. Hernandez, E.A. Buser, T. Tham, M.J. Teuber
Publikováno v:
TP61. TP061 RESIDENTIAL AND OCCUPATIONAL EXPOSURES: WHERE WE LIVE, WORK, AND BREATHE.
From 1985 to 2016, the prevalence of underweight decreased, and that of obesity and severe obesity increased, in most regions, with significant variation in the magnitude of these changes across regions. We investigated how much change in mean body m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fbb8e28b9d73c525f7553e5b7ca9de8a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997202
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997202
Autor:
T. Thamrongjirapat, D. Muntham, P. Incharoen, N. Trachu, P. Sae-Lim, N. Sarachai, K. Khiewngam, N. Monnamo, N. Kantathut, M. Ngodngamthaweesuk, T. Ativitavas, P. Chansriwong, C. Nitiwarangkul, R. Ruangkanchanasetr, A. Kositwattanarerk, E. Sirachainan, T. Dejthevaporn, T. Reungwetwattana
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background EGFR inhibitor and immunotherapy have been approved for adjuvant treatment in resectable non-small cell lung cancer (NSCLC). Limited reports of molecular and clinical characteristics as prognostic factors in NSCLC have been publis
Externí odkaz:
https://doaj.org/article/e2d649e09e984b8d8576d3a09961d2ee